Thyroid hormone and insulin-like growth factor-I in patients with multiple myeloma treated with melphalan and prednisone

Archives of Medical Research

Volumn 37, Issue 1, 2006, Pages 74-78

  Hrycek, Antoni ^a   Gruszka, Andrzej ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Department of Internal Medicine ^*  (Poland)

Author keywords

Hormones; IGF I; Multiple myeloma; Treatment

Indexed keywords

HUMAN GROWTH HORMONE; LIOTHYRONINE; MELPHALAN; PREDNISONE; SOMATOMEDIN C; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; PROLACTIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EUTHYROID SICK SYNDROMES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PREDNISONE; THYROID HORMONES;

EID: 28444498417     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.04.015     Document Type: Article

References (41)

1. J.E. Blalock The syntax of immune-neuroendocrine communication Immunol Today 15 1994 504 511
2. J. Komorowski Hypothalamic-pituitary-thyroid axis and the immune system Endokryn Pol 46 Suppl 1 1995 37 43
3. S. Reichlin Neuroendocrine-immune interactions N Engl J Med 329 1993 1246 1253
4. K. Gadó, G. Nagy, A. Hastiz, B.E. Tóth, E. Rimanóczi, and G. Domjan Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients Neuroimmunomodulation 9 2001 95 102
5. A. Hrycek Prolactin in immunological processes Wiad Lek 51 1998 226 233
6. R. Kooijman, E.L. Hooghe-Peters, and R. Hooghe Prolactin, growth hormone, and insulin-like factor-I in the immune system Adv Immunol 63 1996 377 454
7. A. Hrycek, P. Cieślik, J. Tustanowski, S. Nowak, and P. Jedynak Selected serum cytokines in systemic lupus erythematosus treated with quinagolide Lupus 10 2001 424 430
8. O. Vera-Latra, C. Mendez, L.J. Jara, M. Cisneros, G.A. Medina, R. Ariza, and L.R. Espinoza Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment J Rheumatol 30 2003 2140 2146
9. B.G.M. Durie, and S.E. Salmon A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Cancer 36 1975 842 854
10. B.G.M. Durie Concise Review of the Disease and Treatment Options. Multiple Myeloma. Cancer of the Bone Marrow. International Myeloma Foundation USA Edition 2005
11. W. Oktaba Elements of Mathematical Statistics and Investigational Methodology 1966 Polish Scientific Publishers Warsaw
12. J. Berczi The immunology of prolactin Semin Reprod Endocrinol 10 1992 196 219
13. I.C. Chikanza Prolactin and neuroimmunomodulation: in vitro and in vivo observations Ann NY Acad Sci 876 1999 119 130
14. K. Gadó, E. Rimanóczi, A. Hasitz, G. Gigler, B.E. Tóth, G.M. Nagy, K. Palóczi, and G. Domjan Elevated levels of serum prolactin in patients with advanced multiple myeloma Neuroimmunomodulation 9 2001 231 236
15. V. Chandrashekar, and A. Bartke The role of insulin-like growth factor-I in neuroendocrine function and the consequent effects on sexual maturation: interferences from animal models Reprod Biol 3 2003 7 28
16. D. Kajdaniuk, and B. Marek Insulin-like growth factor-I (IGF-I) and neoplasms Post N Med 12 1999 34 38
17. J.D. Shaughnessy Myeloma is on the move Blood 103 2004 9 10
18. Y.W. Qiang, L. Yao, G. Tosato, and S. Rudikoff Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells Blood 103 2004 301 308
19. M. Ferlin, N. Noraz, C. Hertogh, J. Brochier, N. Taylor, and B. Klein Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway Br J Haematol 111 2000 626 634
20. N.L. Ge, and S. Rudikoff Insulin-like growth factor I is a dual effector of multiple myeloma cell growth Blood 96 2000 2856 2861
21. D.F. Jelinek, T.E. Witzig, and B.K. Arendt A role for insulin-like growth factor in the regulation of IL-6 responsive human myeloma cell line growth J Immunol 159 1997 487 496
22. T. Standal, M. Borset, S. Lenhoff, F. Wisloff, B. Stordal, A. Sundan, A. Waage, and C. Seidel Serum insulin growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor Blood 100 2002 3925 3929
23. M.S. Bitar Insulin and glucocorticoid-dependent supression of the IGF-I system in diabetic wounds Surgery 127 2000 687 695
24. A.M. Delany, and E. Canalis Transcriptional repression of insuline-like growth factor I by glucocorticoids in rat bone cells Endocrinology 136 1995 4776 4781
25. R.C. Pereira, F. Blanguaert, and E. Canalis Cortisol enhances the expression of mac 25/insulin like growth factor-binding protein-related protein-1 in cultured osteoblasts Endocrinology 140 1999 228 232
26. M.M. Viveiros, and R.M. Liptrap Glucocorticoid influence on porcine granulosa cell IGF-I and steroid hormone production in vitro Theriogenology 51 1999 1027 1043
27. S. Watson, R.J. Porter, and A.H. Young Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone Psychopharmacology (Berl) 152 2000 40 46
28. J.P. Miell, A.M. Taylor, and J. Jones The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers J Endocrinol 136 1993 525 533
29. M.H. Borges, A.C. Pinto, F.B. DiNinno, C. Camacho-Hubner, A. Grossman, C.E. Kater, and A.M. Lengyel IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man J Endocrinol Invest 22 1999 12 17
30. M.F. Prummel, W.M. Wiersinga, H. Oosting, and E. Endert The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-1 J Endocrinol Invest 19 1996 620 623
31. A. Hrycek Functional characterisation of peripheral blood neutrophils in patients with hyperthyroidism Folia Biol (Praha) 41 1995 79 87
32. A. Hrycek Functional characterisation of peripheral blood neutrophils in patients with hypothyroidism Folia Biol (Praha) 39 1993 304 310
33. H.C.T. van Zaanen, Y.A. Romijn, H.P. Sanerwein, H.M. Lokhorst, S.O. Warnaar, L.A. Aarden, E. Endert, and M.H.J. van Oers Modulation of chronic excessive interleukin-6 production in multiple myeloma does not affect thyroid hormone concentrations Metabolism 46 1997 1343 1348
34. R. Docter, E.P. Krenning, M. de Jong, and G. Hennemann The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism Clin Endocrinol 39 1993 499 518
35. U. Tellini, L. Pellizzarii, and B. Pravadelli Thyroid function in elderly with neoplasms Minerva Med 90 1999 111 121
36. M. Di Napoli, G. Reda, G. Zannoni, S. Russo, and G. Morace Vasselli C.The euthyroid sick syndrome. Its incidence and clinical significance in an internal medicine department Minerva Med 85 1994 161 165
37. B. McIver, and C.A. Gorman Euthyroid sick syndrome: an overview Thyroid 7 1997 125 132
38. T. Kimura, T. Kanda, N. Kotajima, A. Kuwabara, Y. Fukumura, and I. Kobayashi Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction Eur J Endocrinol 143 2000 179 184
39. I. Molnar, and L. Czirjak Euthyroid sick syndrome and inhibitory effect of sera on the activity of thyroid 5′-deiodinase in systemic sclerosis Clin Exp Rheumatol 18 2000 719 724
40. H. Nellen-Hummel, G. Gutierrez Espindola, J. Talavera, F. Gordon, J. Halabe, and G. Flores Effect of chemotherapy on thyroid hormone concentration in patients with malignant hematologic diseases Arch Med Res 28 1997 215 217
41. G. Mazzoccoli, S. Carughi, A. De Cata, M. La Viola, A. Giuliani, R. Tarquini, and F. Perfetto Neuroendocrine alterations in lung cancer patients Neuroendocrinol Lett 24 2003 77 82